Abstract

BackgroundThe ability to predict risk allows healthcare providers to propose which patients might benefit most from certain therapies, and is relevant to payers’ demands to justify clinical and economic value. To understand the robustness of risk prediction models for heart failure (HF), we conducted a systematic literature review to (1) identify HF risk-prediction models, (2) assess statistical approach and extent of validation, (3) identify common variables, and (4) assess risk of bias (ROB).MethodsLiterature databases were searched from March 2013 to May 2018 to identify risk prediction models conducted in an out-of-hospital setting in adults with HF. Distinct risk prediction variables were ranked according to outcomes assessed and incorporation into the studies. ROB was assessed using Prediction model Risk Of Bias ASsessment Tool (PROBAST).ResultsOf 4720 non-duplicated citations, 40 risk-prediction publications were deemed relevant. Within the 40 publications, 58 models assessed 55 (co)primary outcomes, including all-cause mortality (n = 17), cardiovascular death (n = 9), HF hospitalizations (n = 15), and composite endpoints (n = 14). Few publications reported detail on handling missing data (n = 11; 28%). The discriminatory ability for predicting all-cause mortality, cardiovascular death, and composite endpoints was generally better than for HF hospitalization. 105 distinct predictor variables were identified. Predictors included in >5 publications were: N-terminal prohormone brain-natriuretic peptide, creatinine, blood urea nitrogen, systolic blood pressure, sodium, NYHA class, left ventricular ejection fraction, heart rate, and characteristics including male sex, diabetes, age, and BMI. Only 11/58 (19%) models had overall low ROB, based on our application of PROBAST. In total, 26/58 (45%) models discussed internal validation, and 14/58 (24%) external validation.ConclusionsThe majority of the 58 identified risk-prediction models for HF present particular concerns according to ROB assessment, mainly due to lack of validation and calibration. The potential utility of novel approaches such as machine learning tools is yet to be determined.Registration numberThe SLR was registered in Prospero (ID: CRD42018100709).

Highlights

  • The majority of the 58 identified risk-prediction models for Heart failure (HF) present particular concerns according to risk of bias (ROB) assessment, mainly due to lack of validation and calibration

  • The systematic review of the literature (SLR) was registered in Prospero (ID: CRD42018100709)

  • Heart failure (HF) is a primary cause of death and disability throughout the world [1], and as advancing age is a distinct predictor of in-hospital mortality and complications in HF [2], the prevalence and incidence of HF is predicted to continue to rise as the population ages [1, 3]

Read more

Summary

Introduction

Heart failure (HF) is a primary cause of death and disability throughout the world [1], and as advancing age is a distinct predictor of in-hospital mortality and complications in HF [2], the prevalence and incidence of HF is predicted to continue to rise as the population ages [1, 3]. It would be of benefit to healthcare providers and payers to be able to stratify patients based on risk of future outcomes, to optimize treatment strategies across patients with different needs. This affords the opportunity to propose which HF patients might benefit most from given therapies, while responding to the payers’ demands for clinical and economic value. The ability to predict risk allows healthcare providers to propose which patients might benefit most from certain therapies, and is relevant to payers’ demands to justify clinical and economic value. To understand the robustness of risk prediction models for heart failure (HF), we conducted a systematic literature review to (1) identify HF risk-prediction models, (2) assess statistical approach and extent of validation, (3) identify common variables, and (4) assess risk of bias (ROB)

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.